| Financial Year |
March 31 2022 |
| Monetary Funds |
70,304,558.67 |
| Held-for-trading Financial Assets |
291,993,174.91 |
| Notes Receivable |
70,865,770.15 |
| Accounts Receivable |
108,029,559.45 |
| Advances to Suppliers |
2,007,323.73 |
| Other Receivables |
5,964,192.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,332,350.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,487,146.47 |
| Total Current Assets |
718,984,077.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
56,597,569.69 |
| Under-construction Projects |
23,466,581.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,450,395.37 |
| R&D expenses |
-- |
| Goodwill |
454,348,487.92 |
| Long-Term Deferred and Prepaid Expenses |
630,193.41 |
| Deferred Income Tax Assets |
7,610,998.85 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
621,663,598.00 |
| Total Assets |
1,340,647,675.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,685,344.99 |
| Accounts Payable |
50,790,700.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,208,398.88 |
| Taxes Payable |
14,874,956.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
262,673.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,475,403.30 |
| Other Current Liabilities |
2,187,948.45 |
| Sub-Total of Current Liabilities |
129,267,030.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,889,411.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,887,400.21 |
| Total Liabilities |
200,154,430.56 |
| Paid-In Capital(Or Share Stock) |
139,885,251.00 |
| Capital Surplus |
717,554,090.20 |
| Surplus Reserve |
13,667,883.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
264,403,888.98 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,140,493,244.56 |
| Owner's Equity（Stockholder's Equity） |
1,140,493,244.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,340,647,675.12 |
